A matter of time

Annapurani V | Updated on November 17, 2020 Published on November 16, 2020

The race to develop a Covid-19 vaccine is getting heated. Yesterday, Moderna announced that its RNA-based vaccine was 94.5 per cent effective in preventing the virus. Last week, Pfizer and BioNTech announced that their Covid vaccine was more than 90 per cent effective in the first results of the Phase 3 study. Here's a look at their trial progress, estimated capacities of vaccine manufacturers and more







Follow us on Telegram, Facebook, Twitter, Instagram, YouTube and Linkedin. You can also download our Android App or IOS App.

Published on November 16, 2020
  1. Comments will be moderated by The Hindu Business Line editorial team.
  2. Comments that are abusive, personal, incendiary or irrelevant cannot be published.
  3. Please write complete sentences. Do not type comments in all capital letters, or in all lower case letters, or using abbreviated text. (example: u cannot substitute for you, d is not 'the', n is not 'and').
  4. We may remove hyperlinks within comments.
  5. Please use a genuine email ID and provide your name, to avoid rejection.